BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 11230736)

  • 1. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
    Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
    Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
    Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
    Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
    Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y; Xie WF; Chen YX; Zhang X; Zeng X; Qiang H; Chen WZ; Yang XJ; Han ZG; Zhang ZB
    Liver Int; 2005 Aug; 25(4):796-807. PubMed ID: 15998431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice.
    Locaputo S; Carrick TL; Bezerra JA
    Hepatology; 1999 Apr; 29(4):1106-13. PubMed ID: 10094954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H; Vohra BP; Zhang Y; Heuckeroth RO
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy.
    Li W; Liang X; Leu JI; Kovalovich K; Ciliberto G; Taub R
    Hepatology; 2001 Jun; 33(6):1377-86. PubMed ID: 11391526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy.
    Drixler TA; Vogten JM; Gebbink MF; Carmeliet P; Voest EE; Borel Rinkes IH
    Br J Surg; 2003 Nov; 90(11):1384-90. PubMed ID: 14598419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration.
    Mars WM; Liu ML; Kitson RP; Goldfarb RH; Gabauer MK; Michalopoulos GK
    Hepatology; 1995 Jun; 21(6):1695-701. PubMed ID: 7768515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration.
    Mohammed FF; Pennington CJ; Kassiri Z; Rubin JS; Soloway PD; Ruther U; Edwards DR; Khokha R
    Hepatology; 2005 Apr; 41(4):857-67. PubMed ID: 15726641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.
    Khai NC; Takahashi T; Ushikoshi H; Nagano S; Yuge K; Esaki M; Kawai T; Goto K; Murofushi Y; Fujiwara T; Fujiwara H; Kosai K
    J Hepatol; 2006 Jun; 44(6):1046-54. PubMed ID: 16466829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor as well as vascular endothelial growth factor gene induction effectively promotes liver regeneration after hepatectomy in Solt-Farber rats.
    Oe H; Kaido T; Mori A; Onodera H; Imamura M
    Hepatogastroenterology; 2005; 52(65):1393-7. PubMed ID: 16201081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
    Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of c-myc mRNA after completion of liver regeneration in transgenic mice expressing hepatocyte growth factor in liver.
    Shiota G; Kawasaki H; Nakamura T; Schmidt EV
    Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):259-68. PubMed ID: 8680795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z; Mizuno S; Nakamura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice.
    Olle EW; Ren X; McClintock SD; Warner RL; Deogracias MP; Johnson KJ; Colletti LM
    Hepatology; 2006 Sep; 44(3):540-9. PubMed ID: 16941692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy.
    Sakamoto T; Liu Z; Murase N; Ezure T; Yokomuro S; Poli V; Demetris AJ
    Hepatology; 1999 Feb; 29(2):403-11. PubMed ID: 9918916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.